US Patent 11168126 Recombinant elastin and production thereof
Patent 11168126 was granted and assigned to Geltor on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+345 characters)
Article
Patent abstract
This disclosure provides non-naturally occurring truncated elastin molecules. The non-naturally occurring truncated elastin may improve the firmness, elasticity, brightness, hydration, tactile texture, and/or visual texture of skin. The non-naturally occurring truncated elastin may reduce degradation of the extracellular matrix.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111681260
Date of Patent
November 9, 2021
0Patent Application Number
202004090
Date Filed
April 9, 2020
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111681260
Date of Patent
November 9, 2021
0Patent Application Number
202004090
Date Filed
April 9, 2020
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Nov, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11168126 Recombinant elastin and production thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11168126
Date of patent
November 9, 2021
Patent application number
20200409
Date Filed
April 9, 2020
Patent primary examiner
Find more entities like US Patent 11168126 Recombinant elastin and production thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
